activins and Lung Neoplasms
activins has been researched along with Lung Neoplasms in 15 studies
Research
Studies (15)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 1 (6.67) | 29.6817 |
2010's | 8 (53.33) | 24.3611 |
2020's | 5 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Bostantzoglou, C; Fari, O; Gaga, M; Morianos, I; Photiades, A; Potaris, K; Semitekolou, M; Tsitsopoulou, A; Valakos, D; Vatsellas, G; Xanthou, G | 1 |
Barany, N; Boettiger, K; Dome, B; Grusch, M; Hegedus, B; Hoda, MA; Hoetzenecker, K; Lang, C; Laszlo, V; Megyesfalvi, Z; Paku, S; Renyi-Vamos, F; Rozsas, A; Schelch, K; Schwendenwein, A; Tisza, A | 1 |
Chin, V; Daneshvar, D; Karikios, D; Lim, J; McCloy, R; Murphy, A; Nagrial, A; O'Toole, S; Steinmann, AM; Wong, S | 1 |
Emoto, N; Funaki, S; Hara, T; Ishii, M; Kikuta, J; Kimura, K; Liu, YC; Matsui, T; Miyamoto, Y; Morii, E; Motooka, D; Okuzaki, D; Shintani, Y; Sudo, T; Taniguchi, S; Uchida, Y | 1 |
Ilonen, I; Järvinen, T; Koli, K; Lauri, H; Lemström, K; Myllärniemi, M; Ollila, H; Paajanen, J; Räsänen, J; Ritvos, O; Rouvinen, E; Sutinen, E | 1 |
Alamgeer, M; Barrow, R; Boolell, V; Burgess, A; Cain, JE; Chin, V; Croucher, DR; de Kretser, DM; Ganju, V; Gonzalez-Rajal, A; Han, JZR; Harrison, CA; Hastings, JF; Hedger, MP; Jayasekara, WSN; Kita, B; Kostyrko, K; Kumar, B; Lee, HC; Lorensuhewa, N; Marini, KD; Marquez, C; Martelotto, LG; McCloy, RA; Oakes, SR; Robinson, BW; Rossello, FJ; Sweet-Cordero, EA; Szczepny, A; Vaghjiani, V; Watkins, DN; Waugh, T; Wu, J | 1 |
Baek, JY; Hong, DS; Hong, S; Hong, YS; Hwang, IG; Jang, JS; Kim, HJ; Kim, JH; Kim, JW; Kim, SH; Kim, TY; Lee, JH; Shin, SH; Sun, S; Woo, IS | 1 |
Allison, DF; Bekiranov, S; Clift, SH; Hoang, SA; Holzknecht, CM; Jones, DR; Kumar, M; Mayo, MW; Moskaluk, CA; Szymura, SJ; Wamsley, JJ; Xu, X | 1 |
Koli, K; Myllärniemi, M; Pasternack, A; Ritvos, O; Rönty, M; Sutinen, E; Tamminen, JA; Yin, M | 1 |
de Barsy, M; Frateur, L; Gruson, D; Lause, P; Loumaye, A; Nachit, M; Thissen, JP; Trefois, P; van Maanen, A | 1 |
Li, S; Shan, Y | 1 |
Bendek, M; Berger, W; Berta, J; Dome, B; Grusch, M; Hegedus, B; Hoda, MA; Klepetko, W; Klikovits, T; Lang, E; Laszlo, V; Lohinai, Z; Renyi-Vamos, F; Rozsas, A; Torok, S | 1 |
Aigner, C; Bendek, M; Berger, W; Brcic, L; Dome, B; Dong, Y; Frauenfelder, T; Ghanim, B; Grusch, M; Hegedus, B; Hoda, MA; Jakopovic, M; Kao, SC; Kirschner, MB; Klepetko, W; Klikovits, T; Laszlo, V; Nguyen-Kim, TD; Opitz, I; Ozsvar, J; Reid, G; Rozsas, A; Samarzija, M; Stockhammer, P; Szirtes, I; van Zandwijk, N; Weder, W | 1 |
Feng, Y; Liu, Q; Ning, Y; Ou, X; Song, X; Wang, B; Wen, F; Yang, J; Zhang, X | 1 |
Afrakhte, M; Heldin, CH; Heldin, NE; Itoh, S; Jossan, S; Morén, A; Sampath, K; ten Dijke, P; Westermark, B | 1 |
Other Studies
15 other study(ies) available for activins and Lung Neoplasms
Article | Year |
---|---|
Activin-A impedes the establishment of CD4
Topics: Activins; Adoptive Transfer; Animals; Biomarkers; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Disease Progression; Disease Susceptibility; Gene Expression Regulation, Neoplastic; HMGB Proteins; Humans; Immunity, Cellular; Immunophenotyping; Lung Neoplasms; Lymphocyte Count; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Transgenic; Signal Transduction | 2021 |
Clinical relevance of circulating activin A and follistatin in small cell lung cancer.
Topics: Activins; Follistatin; Humans; Lung Neoplasms; Small Cell Lung Carcinoma | 2021 |
Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer.
Topics: Activins; Adult; Biomarkers; Bone Morphogenetic Proteins; Carcinoma, Non-Small-Cell Lung; Growth Differentiation Factors; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum; Prospective Studies; Retrospective Studies; Transforming Growth Factor beta; Transforming Growth Factors | 2022 |
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma.
Topics: Activins; Animals; Carcinoma; Follistatin; Humans; Lung; Lung Neoplasms; Macrophages, Alveolar; Mice | 2023 |
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy.
Topics: Activins; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cachexia; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mesothelioma, Malignant; Middle Aged; Platinum; Pleural Neoplasms; Prognosis; Prospective Studies; Retrospective Studies; ROC Curve | 2020 |
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy.
Topics: A549 Cells; Activins; Adenocarcinoma of Lung; Animals; Carboplatin; Cell Line, Tumor; Cell Survival; Follistatin; Humans; Lung Neoplasms; Male; Mice; Platinum; Signal Transduction; Xenograft Model Antitumor Assays | 2018 |
Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors.
Topics: Activins; Aged; Aged, 80 and over; Antineoplastic Agents; Biliary Tract Neoplasms; Biomarkers; C-Reactive Protein; Chemokine CXCL10; Collagen Type I; Colonic Neoplasms; Decision Trees; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibronectins; Humans; Interleukin-6; Liver Neoplasms; Lung Neoplasms; Male; Mortality; Myostatin; Neoplasm Metastasis; Neoplasms; Peptides; Prognosis; Republic of Korea; Sirtuin 1; Stomach Neoplasms; Survival Rate; Vascular Endothelial Growth Factor A; Vitamin D | 2019 |
Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.
Topics: Activins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; Inhibin-beta Subunits; Lung Neoplasms; Mesoderm; Neoplastic Stem Cells; NF-kappa B; RNA, Neoplasm; Spheroids, Cellular; Up-Regulation | 2015 |
Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Activins; Aged; Cell Movement; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Invasiveness; Smad3 Protein | 2015 |
Role of Activin A and myostatin in human cancer cachexia.
Topics: Activins; Adult; Aged; Aged, 80 and over; Body Composition; Cachexia; Colorectal Neoplasms; Cross-Sectional Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myostatin; Prospective Studies; Quality of Life | 2015 |
Expression of Cripto-1 gene protein and Activin-A in human lung adenocarcinoma tissue.
Topics: Activins; Adenocarcinoma; Adenocarcinoma of Lung; Biomarkers, Tumor; Female; GPI-Linked Proteins; Humans; Immunohistochemistry; Inhibin-beta Subunits; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Predictive Value of Tests | 2015 |
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.
Topics: Activins; Adenocarcinoma; Adenocarcinoma of Lung; Biomarkers, Tumor; Case-Control Studies; Cell Proliferation; Female; Follistatin; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Survival Rate; Tumor Cells, Cultured | 2016 |
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Topics: Activins; Aged; Biomarkers, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Prognosis | 2016 |
Involvement of ERK, Bcl-2 family and caspase 3 in recombinant human activin A-induced apoptosis in A549.
Topics: Activins; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins | 2009 |
Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members.
Topics: Activins; Animals; Bone Morphogenetic Proteins; Cell Line; DNA-Binding Proteins; Drug Synergism; Epidermal Growth Factor; Epithelial Cells; Gene Expression; Humans; Inhibins; Keratinocytes; Lung; Lung Neoplasms; Mink; RNA, Messenger; Signal Transduction; Smad6 Protein; Smad7 Protein; Tetradecanoylphorbol Acetate; Trans-Activators; Transforming Growth Factor beta; Tumor Cells, Cultured | 1998 |